Background Previous studies suggest that coronavirus disease 2019 (COVID-19) is a
systemic infection involving multiple systems, and may cause autonomic dysfunction …

Background We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as
a serious, multisystem, disorder, including various neurological manifestations in its …

Long-COVID-19 refers to the signs and symptoms that continue or develop after the “acute
COVID-19” phase. These patients have an increased risk of multiorgan dysfunction …

Although autonomic dysfunction (AD) after the recovery from Coronavirus disease 2019
(COVID-19) has been thoroughly described, few data are available regarding the …

In December 2019, a novel coronavirus-related disease (Covid-19) emerged in Wuhan,
China, caused by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). This …

Objectives The novel corona virus disease, which was initially reported in China in late
2019, has become a global pandemic affecting 330 million cases. COVID-19 affects …

Although several clinical manifestations of persistent long coronavirus disease (COVID-19)
have been documented, their effects on the cardiovascular and autonomic nervous system …

Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

Increasing numbers of COVID-19 patients, continue to experience symptoms months after
recovering from mild cases of COVID-19. Amongst these symptoms, several are related to …

Background Autonomic dysfunction may occur during the acute phase of COVID‐19. Heart
rate variability (HRV) is a useful tool for the assessment of cardiac sympathetic and …